Newsroom

18-05-22 - Press Release

Successful Wyss Zurich model receives further donation of around CHF 100 million

Having funded more than 20 projects, some of which have already been successfully brought to market, Wyss Zurich has established itself in Zurich, a center of innovation. Now it will be receiving another donation of around CHF 100 million from its initiator, Dr. h.c. mult. Hansjörg Wyss, ensuring its operations for another six to eight years. Read the full press release.

read more

17-05-22 - News

Gallatin Award - Swiss Science Celebrates Hansjörg Wyss

More than half a billion Swiss francs have been granted over 10 years to groundbreaking research projects in Switzerland within three different Wyss Centers or Academy in Zurich, Geneva and Bern. This makes entrepreneur and philanthropist Hansjörg Wyss one of the major private donors for Swiss science. Wyss was celebrated in Geneva on May 17, 2022 as the laureate of the 2022 Gallatin Award of the Swiss American Chamber of Commerce. The laudatio was given by Federal Councillor Guy Parmelin. The entire Wyss Zurich family warmly congratulates Hansjörg Wyss on this very merited award! Read the full media release.

read more

16-05-22 - Event

Wyss Zurich participates in the Day of Clinical Research at USZ

On May 19, 2022 Wyss Zurich participates in the annual event of the Directorate of Research and Education of University Hospital Zurich (USZ). This year's topic will be: "New Immunotherapies at the USZ". Participation is free of charge. Take a look at the program and visit us there...

read more

10-05-22 - Event

#SUD22: Wyss Zurich at Startup Days in Berne on May 19, 2022

Wyss Zurich will be present at #SUD22. Together with our projects hemotune, MUVON, Nanoflex, and Voliro you will find us at our booth in the Exhibition & Exchange Area. Visit us on May 19, 2022 in Berne and exchange ideas one-to-one with our projects. In addition, MUVON Therapeutics AG has reached the semi-finals and will be pitching live in the Healthtech section. Also, discover more than 100 brilliant speakers and the 50 insightful sessions divided into four tracks: Inspiration, Learning, Scaling and Pitching. You'll expand your skills, think outside the box, and meet new like-minded startup enthusiasts. If you don't have a ticket yet, you can still order it now: https://www.startupdays.ch/ticket/

read more

07-05-22 - Media Coverage

Badische Neueste Nachrichten - World-renowned robotics researcher Roland Siegwart honored with Ernst-Blickle-Award

Congratulations to our Wyss Zurich Founding Co-Director Roland Siegwart! Robots are ubiquitous. With prize money of 100,000 euros, the SEW Foundation in Bruchsal is honoring a robotics researcher who has made a decisive contribution to their development: Roland Siegwart, professor at the Institute of Robotics and Intelligent Systems at ETH Zurich, received the award for his contributions to the development and control of robotic systems. He had also rendered outstanding services in turning research results into marketable products. Numerous start-ups can be traced back to his initiative. The honoree dedicated the €100,000 prize to his young scientists. "They are the ones who carry our visions out into the world," Siegwart thanked them after the award ceremony in the Fürstensaal of Bruchsal Castle.

read more

26-04-22 - Press Release

hemotune raises CHF 7.25 million Series B1 funding for the development of their disruptive blood purification platform

hemotune AG, a spin-off from ETH Zurich founded in 2017 and currently being accelerated by Wyss Zurich, today announced the closing of a CHF 7.25 million Series B1 for the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads. The investment consortium was led by OCCIDENT with participation of all previous investors including Zürcher Kantonalbank and joined by the new investors HEMEX, VP Venture Partners as well as a global family office and private individuals.

read more

21-04-22 - News

Recolony among 52 >>venture>> Finalists 2022

Another great news: our latest project Recolony has been selected as finalist of the >>venture>> Startup Competition in the Health & Nutrition vertical. Recolony is developing a bacteria-based cancer therapy. They will pitch in Zurich on May 19th, 2022.

read more

20-04-22 - News

hemotune among finalists for Swiss Economic Award

hemotune has been selected as one of the finalists for the 2022 Swiss Economic Award in the category high-tech/biotech. The Swiss Economic Award is the most important young entrepreneur prize in Switzerland and honors outstanding entrepreneurial achievements in the three categories of services, high-tech/biotech and production/trade & industry. Congratulations to Project Leader Lukas Langenegger, Carlos Mora and their entire team!

read more

19-04-22 - News

MUVON - Project Leader Deana Mohr listed among "In Vivo's 2022 Rising Leaders"

Congratulations to MUVON Project Leader Deana Mohr for being named to the "In Vivo's 2022 Rising Leaders" list. The third annual listing includes 30 entrepreneurs and innovators from across the world who are leaders in biopharma, medtech and health technology sectors.

read more

06-04-22 - Event

The Wyss Zurich workshop - for school classes of the secondary level I and II

Are you keen on having the unique opportunity to dive into the worlds of medicine and robotics? Wyss Zurich offers its very first workshop on May 24. The workshop is aimed at school classes of the secondary level I and II. In a three-hour workshop, the classes have the exclusive opportunity to visit two of the Wyss Zurich projects, go on a magic cube mission with mint & pepper, explore the Wyss Zurich Robotics Technologies Platform equipped with a 3D printer, and much more.

read full article